N,N'- monomethylenebis(pyridiniumaldoxime)

Subscribe to Selected New Research on N,N'-monomethylenebis(pyridiniumaldoxime)

13 relevant articles (3 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd

Also Known As:

1,1'-methylenebis(4-((hydroxyimino)methyl)pyridinium); MMB 4; MMB-4; N,N'-monomethylenebis(pyridiniumaldoxime) dibromide; N,N'-monomethylenebis(pyridiniumaldoxime) dichloride; methoxime

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Amines: 1233

Hydroxylamines: 11

Oximes: 229

N,N'-monomethylenebis(pyridiniumaldoxime): 13

Related Diseases

1.	Poisoning 02/01/2005 - "The significantly (P < 0.05) lowest effectivity in treatment of supralethal GF-agent poisoning in comparison with all the other therapeutic regimens, was surprisingly observed for methoxime" 01/01/1975 - "The effect of atropine (constant dose) and methoxime (different doses) on acetylcholinesterase (AChE) activity in four parts of the mouse brain following isopropyl methylphosphonofluoridate intoxication was described" 12/15/1990 - "These observations indicate that ICD 467 would be contraindicated as a therapy for anti-ChE intoxication and that the efficacy of HI-6 or MMB-4 can be explained, in part, by reactivation of soman-inhibited AChE." 01/01/1975 - "The antidotal action of atropine with trimedoxime, obidoxime or methoxime against isopropyl methylphosphonofluoridate intoxication in mice was studied" 01/01/2004 - "Obidoxime and trimedoxime that were combined with atropine were less effective than methoxime and HI-6 in combination with BNZ when applied 2 minutes after GF-agent poisoning" Get all the results and reference details, order at left...
2.	Hypertension (High Blood Pressure) 11/01/1979 - "In order to analyse and quantitate the urinary 16-oxysteroids known or thought to be associated with hypertension, we have established for six 16-oxy-C19 reference steroids the following parameters: elution volume on lipophilic gel columns, gas chromatographic retention data expressed as methylene unit values of trimethylsilyl ether and O-methoxime trimethylsilyl ether derivatives on OV-1 and OV-17 packed columns and on SE-30 capillary column, and mass spectra of these compounds" Get all the results and reference details, order at left...
3.	Lactic Acidosis 05/01/2008 - "Simultaneous determination of lactic acid, pyruvic acid, 3-hydroxybutyric acid and acetoacetic acid for clinical monitoring of lactic acidosis and ketone body formation in human plasma (20 microL) was performed by gas chromatography-mass spectrometry in selected ion monitoring (SIM) mode after generating methoxime/tert-butyldimethylsilyl derivatives" Get all the results and reference details, order at left...
3 Diseases and 13 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	HI 6 (H16)
2.	Soman
3.	Obidoxime Chloride (Obidoxime)
4.	Oximes
5.	BI 6
6.	pralidoxime (Protopam Chloride)
7.	Atropine (Hyoscyamine)
8.	Benactyzine
9.	Sarin
10.	Biperiden (Akineton)
28 Drugs and Important Bio-Agents and 12 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>